Finch Therapeutics Group, Inc. FNCHQ
10.35
0.00
0.00%
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow FNCHQ
Growth Flags
show if company had growth for consecutive years
| Jun '24 | Mar '24 | Dec '23 | Sep '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.59 | 5.93 | 6.15 | 5.90 | |
Current Ratio |
3.87 | 6.05 | 6.33 | 6.13 | |
Net Debt/EBITDA |
2.64 | 4.03 | 5.75 | (0.01) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 48.41% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 1.12 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.98 | 1.13 | 1.22 | 2.18 | |
Capex/Depreciation |
0.00 | 0.00 | 1.16 | 0.38 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.94) | (2.72) | (2.31) | (3.28) | |
Capex per Share |
0.00 | 0.00 | 0.03 | 0.01 | |
Free Cash Flow per Share |
(2.94) | (2.72) | (2.28) | (3.27) | |
Cash per Share |
9.98 | 12.93 | 15.65 | 17.93 | |
Shareholders Equity per Share |
8.85 | 11.85 | 14.26 | 16.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.85 | 11.85 | 14.26 | 16.08 | |
Free Cash Flow |
(4.73) | (4.36) | (3.65) | (5.24) | |
Working Capital |
12.82 | 17.68 | 21.76 | 25.04 | |
Capital Expenditures |
— | — | 0.05 | 0.02 | |
Net Current Asset Value |
(14.08) | (9.88) | (6.64) | (3.76) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
0.23 | 1.30 | 0.62 | 0.71 | |
Average Assets |
56.22 | 64.57 | 109.16 | 123.73 | |
Average Common Equity |
21.06 | 26.00 | 59.30 | 73.34 |
Columns are period end dates